Monday 19 October 2026
Export PBLS’s income statement to Excel — free account
Parabilis Medicines, Inc.
PBLS
Insiders bought in the last twelve months.
22.75
2.43
−9.65%
Follow PBLS
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+1 more TTM period Free account |
— | — | — | 0.00% | |
| — | — | — | 0.00% | ||
ROIC |
— | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
— | 0.00% | 0.00% | (21.60%) | |
Free Cash Flow per Share |
0.00 | — | 0.00 | (4.12) | |
Free Cash Flow |
— | — | — | (119.14) | |
Capital Expenditures |
— | — | — | (1.07) | |
| Other line items | |||||
Cash ROIC |
— | 0.00% | 0.00% | (5.48%) | |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 0.00% | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Interest Coverage |
— | — | — | (135.00) | |
Operating CF/Net income |
— | — | — | 0.51 | |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.41 | |
Capex/Depreciation |
— | — | — | (0.39) | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | — | 0.00 | (4.08) | |
Capex per Share |
0.00 | — | 0.00 | (0.04) | |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates · fundamentals updated 30 Sep 2026